Polydex Pharm Ltd (POLXF) 0.8520 $POLXF
Polydex Reports Equipment Upgrades and Continued Profitability
GlobeNewswire - Tue Sep 09, 8:19AM CDT
Polydex Pharmaceuticals Limited
Polydex Reports Continued Robust Sales and Continued Earnings; Facility Improvements to Reduce Production Costs
GlobeNewswire - Mon Sep 16, 8:15AM CDT
Polydex Pharmaceuticals Limited (OTC Pink
OLXF) (the "Company"
reports that it has continued to experience high demand for product from its customers, resulting in increasing sales and collaborated investments into production upgrades and planned capital improvements.
Polydex Enters Into New U.S. License Agreement, Receiving $250,000 at Signing and Additional $250,000 on Approval of ANADA
GlobeNewswire - Tue Jul 30, 8:35AM CDT
Polydex Pharmaceuticals Limited (Pink/OTCBB OLXF) (the "Company" is pleased to announce that through its wholly owned subsidiary it has received $250,000 for issuing a new exclusive 10-year supply agreement with Sparhawk Laboratories, Inc. to purchase bulk quantities of materials necessary for production of 20% Bulk Iron Dextran Solution for the United States veterinary industry.
Polydex Updates Company Website www.Polydex.com
GlobeNewswire - Tue Jun 25, 8:00AM CDT
Polydex Pharmaceuticals Limited (Pink Sheets OLXF) (the "Company" has updated the company website at www.Polydex.com with an aim to provide greater transparency and other helpful information to shareholders, investors and interested parties alike.
Polydex Pharmaceuticals Reports Strong Backlog Resulting From Worldwide Increase in Demand for Product in 2013 Fiscal Year End Financial Results
GlobeNewswire - Wed May 01, 12:36AM CDT
Polydex Pharmaceuticals Limited (OTCBB OLXF) (the "Company" reports financial results for its fiscal year ended January 31, 2013. All figures are reported in U.S. dollars.
Polydex Reports Equipment Upgrades and Continued Profitability
GlobeNewswire - Tue Sep 09, 8:19AM CDT
Polydex Pharmaceuticals Limited
Polydex Reports Continued Robust Sales and Continued Earnings; Facility Improvements to Reduce Production Costs
GlobeNewswire - Mon Sep 16, 8:15AM CDT
Polydex Pharmaceuticals Limited (OTC Pink
OLXF) (the "Company" reports that it has continued to experience high demand for product from its customers, resulting in increasing sales and collaborated investments into production upgrades and planned capital improvements. Polydex Enters Into New U.S. License Agreement, Receiving $250,000 at Signing and Additional $250,000 on Approval of ANADA
GlobeNewswire - Tue Jul 30, 8:35AM CDT
Polydex Pharmaceuticals Limited (Pink/OTCBB
OLXF) (the "Company" is pleased to announce that through its wholly owned subsidiary it has received $250,000 for issuing a new exclusive 10-year supply agreement with Sparhawk Laboratories, Inc. to purchase bulk quantities of materials necessary for production of 20% Bulk Iron Dextran Solution for the United States veterinary industry. Polydex Updates Company Website www.Polydex.com
GlobeNewswire - Tue Jun 25, 8:00AM CDT
Polydex Pharmaceuticals Limited (Pink Sheets
OLXF) (the "Company" has updated the company website at www.Polydex.com with an aim to provide greater transparency and other helpful information to shareholders, investors and interested parties alike. Polydex Pharmaceuticals Reports Strong Backlog Resulting From Worldwide Increase in Demand for Product in 2013 Fiscal Year End Financial Results
GlobeNewswire - Wed May 01, 12:36AM CDT
Polydex Pharmaceuticals Limited (OTCBB
OLXF) (the "Company" reports financial results for its fiscal year ended January 31, 2013. All figures are reported in U.S. dollars. 
